Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Abnormalities in Glucose Metabolism, Appetite-Related Peptide Release, and Pro-inflammatory Cytokines Play a Central Role in Appetite Disorders in Peritoneal Dialysis.

Avila-Carrasco L, Pavone MA, González E, Aguilera-Baca Á, Selgas R, Del Peso G, Cigarran S, López-Cabrera M, Aguilera A.

Front Physiol. 2019 May 28;10:630. doi: 10.3389/fphys.2019.00630. eCollection 2019.

2.

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis.

González-Mateo GT, Pascual-Antón L, Sandoval P, Aguilera Peralta A, López-Cabrera M.

J Vis Exp. 2018 Jul 19;(137). doi: 10.3791/56746.

PMID:
30080204
3.

Targeting Toll-like receptors with soluble Toll-like receptor 2 prevents peritoneal dialysis solution-induced fibrosis.

Raby AC, González-Mateo GT, Williams A, Topley N, Fraser D, López-Cabrera M, Labéta MO.

Kidney Int. 2018 Aug;94(2):346-362. doi: 10.1016/j.kint.2018.03.014. Epub 2018 May 31.

PMID:
29861057
4.

Preventing tissue fibrosis by local biomaterials interfacing of specific cryptic extracellular matrix information.

Horejs CM, St-Pierre JP, Ojala JRM, Steele JAM, da Silva PB, Rynne-Vidal A, Maynard SA, Hansel CS, Rodríguez-Fernández C, Mazo MM, You AYF, Wang AJ, von Erlach T, Tryggvason K, López-Cabrera M, Stevens MM.

Nat Commun. 2017 Jun 8;8:15509. doi: 10.1038/ncomms15509.

5.

miR-21 Promotes Fibrogenesis in Peritoneal Dialysis.

Lopez-Anton M, Lambie M, Lopez-Cabrera M, Schmitt CP, Ruiz-Carpio V, Bartosova M, Schaefer B, Davies S, Stone T, Jenkins R, Taylor PR, Topley N, Bowen T, Fraser D.

Am J Pathol. 2017 Jul;187(7):1537-1550. doi: 10.1016/j.ajpath.2017.03.007. Epub 2017 May 9.

PMID:
28495592
6.

Correction: Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis.

Liappas G, González-Mateo G, Aguirre AR, Abensur H, Albar-Vizcaino P, Parra EG, Sandoval P, Ramírez LG, Del Peso G, Acedo JM, Bajo MA, Selgas R, Sánchez Tomero JA, López-Cabrera M, Aguilera A.

Oncotarget. 2017 Apr 4;8(14):24045. doi: 10.18632/oncotarget.16782. No abstract available.

7.

Genomic reprograming analysis of the Mesothelial to Mesenchymal Transition identifies biomarkers in peritoneal dialysis patients.

Ruiz-Carpio V, Sandoval P, Aguilera A, Albar-Vizcaíno P, Perez-Lozano ML, González-Mateo GT, Acuña-Ruiz A, García-Cantalejo J, Botías P, Bajo MA, Selgas R, Sánchez-Tomero JA, Passlick-Deetjen J, Piecha D, Büchel J, Steppan S, López-Cabrera M.

Sci Rep. 2017 Mar 22;7:44941. doi: 10.1038/srep44941.

8.

Corrigendum to "T Helper 17/Regulatory T Cell Balance and Experimental Models of Peritoneal Dialysis-Induced Damage".

Liappas G, Gónzalez-Mateo GT, Majano P, Sánchez-Tomero JA, Ruiz-Ortega M, Rodrigues Díez R, Martín P, Sanchez-Díaz R, Selgas R, López-Cabrera M, Aguilera Peralta A.

Biomed Res Int. 2017;2017:6130208. doi: 10.1155/2017/6130208. Epub 2017 Feb 8.

9.

Mesothelial-to-mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer.

Rynne-Vidal A, Au-Yeung CL, Jiménez-Heffernan JA, Pérez-Lozano ML, Cremades-Jimeno L, Bárcena C, Cristóbal-García I, Fernández-Chacón C, Yeung TL, Mok SC, Sandoval P, López-Cabrera M.

J Pathol. 2017 Jun;242(2):140-151. doi: 10.1002/path.4889. Epub 2017 Apr 3.

10.

Immune-Regulatory Molecule CD69 Controls Peritoneal Fibrosis.

Liappas G, González-Mateo GT, Sánchez-Díaz R, Lazcano JJ, Lasarte S, Matesanz-Marín A, Zur R, Ferrantelli E, Ramírez LG, Aguilera A, Fernández-Ruiz E, Beelen RH, Selgas R, Sánchez-Madrid F, Martín P, López-Cabrera M.

J Am Soc Nephrol. 2016 Dec;27(12):3561-3576. Epub 2016 May 5.

11.

Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis.

Liappas G, González-Mateo G, Aguirre AR, Abensur H, Albar-Vizcaino P, Parra EG, Sandoval P, Ramírez LG, Del Peso G, Acedo JM, Bajo MA, Selgas R, Sánchez Tomero JA, López-Cabrera M, Aguilera A.

Oncotarget. 2016 May 24;7(21):30133-46. doi: 10.18632/oncotarget.8780. Erratum in: Oncotarget. 2017 Apr 4;8(14 ):24045.

12.

Mesothelial-to-mesenchymal transition in the pathogenesis of post-surgical peritoneal adhesions.

Sandoval P, Jiménez-Heffernan JA, Guerra-Azcona G, Pérez-Lozano ML, Rynne-Vidal Á, Albar-Vizcaíno P, Gil-Vera F, Martín P, Coronado MJ, Barcena C, Dotor J, Majano PL, Peralta AA, López-Cabrera M.

J Pathol. 2016 May;239(1):48-59. doi: 10.1002/path.4695. Epub 2016 Mar 23.

PMID:
27071481
13.

The dipeptide alanyl-glutamine ameliorates peritoneal fibrosis and attenuates IL-17 dependent pathways during peritoneal dialysis.

Ferrantelli E, Liappas G, Vila Cuenca M, Keuning ED, Foster TL, Vervloet MG, Lopéz-Cabrera M, Beelen RH.

Kidney Int. 2016 Mar;89(3):625-35. doi: 10.1016/j.kint.2015.12.005. Epub 2016 Jan 8.

PMID:
26880457
14.

Rapamycin Protects from Type-I Peritoneal Membrane Failure Inhibiting the Angiogenesis, Lymphangiogenesis, and Endo-MT.

González-Mateo GT, Aguirre AR, Loureiro J, Abensur H, Sandoval P, Sánchez-Tomero JA, del Peso G, Jiménez-Heffernan JA, Ruiz-Carpio V, Selgas R, López-Cabrera M, Aguilera A, Liappas G.

Biomed Res Int. 2015;2015:989560. doi: 10.1155/2015/989560. Epub 2015 Nov 25.

15.

A Novel Mouse Model of Peritoneal Dialysis: Combination of Uraemia and Long-Term Exposure to PD Fluid.

Ferrantelli E, Liappas G, Keuning ED, Vila Cuenca M, González-Mateo G, Verkaik M, López-Cabrera M, Beelen RH.

Biomed Res Int. 2015;2015:106902. doi: 10.1155/2015/106902. Epub 2015 Oct 26.

16.

Biocompatible Dialysis Solutions Preserve Peritoneal Mesothelial Cell and Vessel Wall Integrity. A Case-Control Study on Human Biopsies.

del Peso G, Jiménez-Heffernan JA, Selgas R, Remón C, Ossorio M, Fernández-Perpén A, Sánchez-Tomero JA, Cirugeda A, de Sousa E, Sandoval P, Díaz R, López-Cabrera M, Bajo MA.

Perit Dial Int. 2016 Mar-Apr;36(2):129-34. doi: 10.3747/pdi.2014.00038. Epub 2015 Oct 16.

17.

The Mesothelial Origin of Carcinoma Associated-Fibroblasts in Peritoneal Metastasis.

Rynne-Vidal A, Jiménez-Heffernan JA, Fernández-Chacón C, López-Cabrera M, Sandoval P.

Cancers (Basel). 2015 Sep 29;7(4):1994-2011. doi: 10.3390/cancers7040872. Review.

18.

miR-9-5p suppresses pro-fibrogenic transformation of fibroblasts and prevents organ fibrosis by targeting NOX4 and TGFBR2.

Fierro-Fernández M, Busnadiego Ó, Sandoval P, Espinosa-Díez C, Blanco-Ruiz E, Rodríguez M, Pian H, Ramos R, López-Cabrera M, García-Bermejo ML, Lamas S.

EMBO Rep. 2015 Oct;16(10):1358-77. doi: 10.15252/embr.201540750. Epub 2015 Aug 27.

19.

Matrix cross-linking lysyl oxidases are induced in response to myocardial infarction and promote cardiac dysfunction.

González-Santamaría J, Villalba M, Busnadiego O, López-Olañeta MM, Sandoval P, Snabel J, López-Cabrera M, Erler JT, Hanemaaijer R, Lara-Pezzi E, Rodríguez-Pascual F.

Cardiovasc Res. 2016 Jan 1;109(1):67-78. doi: 10.1093/cvr/cvv214. Epub 2015 Aug 10.

PMID:
26260798
20.

T Helper 17/Regulatory T Cell Balance and Experimental Models of Peritoneal Dialysis-Induced Damage.

Liappas G, Gónzalez-Mateo GT, Majano P, Sánchez-Tomero JA, Ruiz-Ortega M, Rodrigues Díez R, Martín P, Sanchez-Díaz R, Selgas R, López-Cabrera M, Aguilera Peralta A.

Biomed Res Int. 2015;2015:416480. doi: 10.1155/2015/416480. Epub 2015 May 3. Review. Erratum in: Biomed Res Int. 2017;2017:6130208.

21.

Elevated expression levels of lysyl oxidases protect against aortic aneurysm progression in Marfan syndrome.

Busnadiego O, Gorbenko Del Blanco D, González-Santamaría J, Habashi JP, Calderon JF, Sandoval P, Bedja D, Guinea-Viniegra J, Lopez-Cabrera M, Rosell-Garcia T, Snabel JM, Hanemaaijer R, Forteza A, Dietz HC, Egea G, Rodriguez-Pascual F.

J Mol Cell Cardiol. 2015 Aug;85:48-57. doi: 10.1016/j.yjmcc.2015.05.008. Epub 2015 May 16.

22.

Clathrin mediates infectious hepatitis C virus particle egress.

Benedicto I, Gondar V, Molina-Jiménez F, García-Buey L, López-Cabrera M, Gastaminza P, Majano PL.

J Virol. 2015 Apr;89(8):4180-90. doi: 10.1128/JVI.03620-14. Epub 2015 Jan 28.

23.

Caveolin-1 deficiency induces a MEK-ERK1/2-Snail-1-dependent epithelial-mesenchymal transition and fibrosis during peritoneal dialysis.

Strippoli R, Loureiro J, Moreno V, Benedicto I, Pérez Lozano ML, Barreiro O, Pellinen T, Minguet S, Foronda M, Osteso MT, Calvo E, Vázquez J, López Cabrera M, del Pozo MA.

EMBO Mol Med. 2015 Jan;7(1):102-23. doi: 10.15252/emmm.201404127. Erratum in: EMBO Mol Med. 2015 Mar;7(3):357.

24.

Paricalcitol reduces peritoneal fibrosis in mice through the activation of regulatory T cells and reduction in IL-17 production.

González-Mateo GT, Fernández-Míllara V, Bellón T, Liappas G, Ruiz-Ortega M, López-Cabrera M, Selgas R, Aroeira LS.

PLoS One. 2014 Oct 3;9(10):e108477. doi: 10.1371/journal.pone.0108477. eCollection 2014.

25.

A pathogenetic role for endothelin-1 in peritoneal dialysis-associated fibrosis.

Busnadiego O, Loureiro-Álvarez J, Sandoval P, Lagares D, Dotor J, Pérez-Lozano ML, López-Armada MJ, Lamas S, López-Cabrera M, Rodríguez-Pascual F.

J Am Soc Nephrol. 2015 Jan;26(1):173-82. doi: 10.1681/ASN.2013070799. Epub 2014 Jul 10.

26.

TWEAK promotes peritoneal inflammation.

Sanz AB, Aroeira LS, Bellon T, del Peso G, Jimenez-Heffernan J, Santamaria B, Sanchez-Niño MD, Blanco-Colio LM, Lopez-Cabrera M, Ruiz-Ortega M, Egido J, Selgas R, Ortiz A.

PLoS One. 2014 Mar 5;9(3):e90399. doi: 10.1371/journal.pone.0090399. eCollection 2014.

27.

IL-17A is a novel player in dialysis-induced peritoneal damage.

Rodrigues-Díez R, Aroeira LS, Orejudo M, Bajo MA, Heffernan JJ, Rodrigues-Díez RR, Rayego-Mateos S, Ortiz A, Gonzalez-Mateo G, López-Cabrera M, Selgas R, Egido J, Ruiz-Ortega M.

Kidney Int. 2014 Aug;86(2):303-15. doi: 10.1038/ki.2014.33. Epub 2014 Feb 19.

28.

Mesenchymal Conversion of Mesothelial Cells Is a Key Event in the Pathophysiology of the Peritoneum during Peritoneal Dialysis.

López-Cabrera M.

Adv Med. 2014;2014:473134. doi: 10.1155/2014/473134. Epub 2014 Jan 23. Review.

29.

Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis.

Sandoval P, Jiménez-Heffernan JA, Rynne-Vidal Á, Pérez-Lozano ML, Gilsanz Á, Ruiz-Carpio V, Reyes R, García-Bordas J, Stamatakis K, Dotor J, Majano PL, Fresno M, Cabañas C, López-Cabrera M.

J Pathol. 2013 Dec;231(4):517-31. doi: 10.1002/path.4281.

30.

Tamoxifen ameliorates peritoneal membrane damage by blocking mesothelial to mesenchymal transition in peritoneal dialysis.

Loureiro J, Sandoval P, del Peso G, Gónzalez-Mateo G, Fernández-Millara V, Santamaria B, Bajo MA, Sánchez-Tomero JA, Guerra-Azcona G, Selgas R, López-Cabrera M, Aguilera AI.

PLoS One. 2013 Apr 23;8(4):e61165. doi: 10.1371/journal.pone.0061165. Print 2013.

31.

Functional relevance of the switch of VEGF receptors/co-receptors during peritoneal dialysis-induced mesothelial to mesenchymal transition.

Pérez-Lozano ML, Sandoval P, Rynne-Vidal A, Aguilera A, Jiménez-Heffernan JA, Albar-Vizcaíno P, Majano PL, Sánchez-Tomero JA, Selgas R, López-Cabrera M.

PLoS One. 2013 Apr 9;8(4):e60776. doi: 10.1371/journal.pone.0060776. Print 2013.

32.

Are the Mesothelial-to-Mesenchymal Transition, Sclerotic Peritonitis Syndromes, and Encapsulating Peritoneal Sclerosis Part of the Same Process?

Loureiro J, Gónzalez-Mateo G, Jimenez-Heffernan J, Selgas R, López-Cabrera M, Aguilera Peralta A.

Int J Nephrol. 2013;2013:263285. doi: 10.1155/2013/263285. Epub 2013 Feb 10.

33.

Role of tight junctions in hepatitis C virus infection.

Benedicto I, Molina-Jiménez F, García-Buey L, Gondar V, López-Cabrera M, Moreno-Otero R, Majano PL.

Rev Esp Enferm Dig. 2012 May;104(5):255-63. Review. No abstract available.

34.

Hypoxia inducible factor 1-alpha (HIF-1 alpha) is induced during reperfusion after renal ischemia and is critical for proximal tubule cell survival.

Conde E, Alegre L, Blanco-Sánchez I, Sáenz-Morales D, Aguado-Fraile E, Ponte B, Ramos E, Sáiz A, Jiménez C, Ordoñez A, López-Cabrera M, del Peso L, de Landázuri MO, Liaño F, Selgas R, Sanchez-Tomero JA, García-Bermejo ML.

PLoS One. 2012;7(3):e33258. doi: 10.1371/journal.pone.0033258. Epub 2012 Mar 14.

35.

Inhibition of transforming growth factor-activated kinase 1 (TAK1) blocks and reverses epithelial to mesenchymal transition of mesothelial cells.

Strippoli R, Benedicto I, Perez Lozano ML, Pellinen T, Sandoval P, Lopez-Cabrera M, del Pozo MA.

PLoS One. 2012;7(2):e31492. doi: 10.1371/journal.pone.0031492. Epub 2012 Feb 27.

36.

Matrigel-embedded 3D culture of Huh-7 cells as a hepatocyte-like polarized system to study hepatitis C virus cycle.

Molina-Jimenez F, Benedicto I, Dao Thi VL, Gondar V, Lavillette D, Marin JJ, Briz O, Moreno-Otero R, Aldabe R, Baumert TF, Cosset FL, Lopez-Cabrera M, Majano PL.

Virology. 2012 Mar 30;425(1):31-9. doi: 10.1016/j.virol.2011.12.021. Epub 2012 Jan 24.

37.

Influence of bicarbonate/low-GDP peritoneal dialysis fluid (BicaVera) on in vitro and ex vivo epithelial-to-mesenchymal transition of mesothelial cells.

Fernández-Perpén A, Pérez-Lozano ML, Bajo MA, Albar-Vizcaino P, Sandoval Correa P, del Peso G, Castro MJ, Aguilera A, Ossorio M, Peter ME, Passlick-Deetjen J, Aroeira LS, Selgas R, López-Cabrera M, Sánchez-Tomero JA.

Perit Dial Int. 2012 May-Jun;32(3):292-304. doi: 10.3747/pdi.2010.00315. Epub 2012 Jan 3.

38.

Pharmacological modulation of peritoneal injury induced by dialysis fluids: is it an option?

González-Mateo GT, Aroeira LS, López-Cabrera M, Ruiz-Ortega M, Ortiz A, Selgas R.

Nephrol Dial Transplant. 2012 Feb;27(2):478-81. doi: 10.1093/ndt/gfr543. Epub 2011 Sep 29. No abstract available.

PMID:
21965583
39.

Blocking TGF-β1 protects the peritoneal membrane from dialysate-induced damage.

Loureiro J, Aguilera A, Selgas R, Sandoval P, Albar-Vizcaíno P, Pérez-Lozano ML, Ruiz-Carpio V, Majano PL, Lamas S, Rodríguez-Pascual F, Borras-Cuesta F, Dotor J, López-Cabrera M.

J Am Soc Nephrol. 2011 Sep;22(9):1682-95. doi: 10.1681/ASN.2010111197. Epub 2011 Jul 8.

40.

Interplay among cellular polarization, lipoprotein metabolism and hepatitis C virus entry.

Benedicto I, Molina-Jiménez F, Moreno-Otero R, López-Cabrera M, Majano PL.

World J Gastroenterol. 2011 Jun 14;17(22):2683-90. doi: 10.3748/wjg.v17.i22.2683.

41.

Bowel bacterial overgrowth as another cause of malnutrition, inflammation, and atherosclerosis syndrome in peritoneal dialysis patients.

Aguilera A, Gonzalez-Espinoza L, Codoceo R, Jara Mdel C, Pavone M, Bajo MA, Del Peso G, Celadilla O, Martínez MV, López-Cabrera M, Selgas R.

Adv Perit Dial. 2010;26:130-6.

PMID:
21348395
42.

p38 maintains E-cadherin expression by modulating TAK1-NF-kappa B during epithelial-to-mesenchymal transition.

Strippoli R, Benedicto I, Foronda M, Perez-Lozano ML, Sánchez-Perales S, López-Cabrera M, Del Pozo MÁ.

J Cell Sci. 2010 Dec 15;123(Pt 24):4321-31. doi: 10.1242/jcs.071647. Epub 2010 Nov 23.

43.

Low-GDP peritoneal dialysis fluid ('balance') has less impact in vitro and ex vivo on epithelial-to-mesenchymal transition (EMT) of mesothelial cells than a standard fluid.

Bajo MA, Pérez-Lozano ML, Albar-Vizcaino P, del Peso G, Castro MJ, Gonzalez-Mateo G, Fernández-Perpén A, Aguilera A, Sánchez-Villanueva R, Sánchez-Tomero JA, López-Cabrera M, Peter ME, Passlick-Deetjen J, Selgas R.

Nephrol Dial Transplant. 2011 Jan;26(1):282-91. doi: 10.1093/ndt/gfq357. Epub 2010 Jun 22.

PMID:
20571097
44.

PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage.

Sandoval P, Loureiro J, González-Mateo G, Pérez-Lozano ML, Maldonado-Rodríguez A, Sánchez-Tomero JA, Mendoza L, Santamaría B, Ortiz A, Ruíz-Ortega M, Selgas R, Martín P, Sánchez-Madrid F, Aguilera A, López-Cabrera M.

Lab Invest. 2010 Oct;90(10):1517-32. doi: 10.1038/labinvest.2010.111. Epub 2010 Jun 7.

45.

Expression of pituitary tumor-transforming gene 1 (PTTG1)/securin in hepatitis B virus (HBV)-associated liver diseases: evidence for an HBV X protein-mediated inhibition of PTTG1 ubiquitination and degradation.

Molina-Jiménez F, Benedicto I, Murata M, Martín-Vílchez S, Seki T, Antonio Pintor-Toro J, Tortolero M, Moreno-Otero R, Okazaki K, Koike K, Barbero JL, Matsuzaki K, Majano PL, López-Cabrera M.

Hepatology. 2010 Mar;51(3):777-87. doi: 10.1002/hep.23468.

46.

BMP-7 blocks mesenchymal conversion of mesothelial cells and prevents peritoneal damage induced by dialysis fluid exposure.

Loureiro J, Schilte M, Aguilera A, Albar-Vizcaíno P, Ramírez-Huesca M, Pérez-Lozano ML, González-Mateo G, Aroeira LS, Selgas R, Mendoza L, Ortiz A, Ruíz-Ortega M, van den Born J, Beelen RH, López-Cabrera M.

Nephrol Dial Transplant. 2010 Apr;25(4):1098-108. doi: 10.1093/ndt/gfp618. Epub 2010 Jan 12.

PMID:
20067910
47.

The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection.

Benedicto I, Molina-Jiménez F, Bartosch B, Cosset FL, Lavillette D, Prieto J, Moreno-Otero R, Valenzuela-Fernández A, Aldabe R, López-Cabrera M, Majano PL.

J Virol. 2009 Aug;83(16):8012-20. doi: 10.1128/JVI.00038-09. Epub 2009 Jun 10.

48.

Chronic exposure of mouse peritoneum to peritoneal dialysis fluid: structural and functional alterations of the peritoneal membrane.

González-Mateo GT, Loureiro J, Jiménez-Hefferman JA, Bajo MA, Selgas R, López-Cabrera M, Aroeira LS.

Perit Dial Int. 2009 Mar-Apr;29(2):227-30. No abstract available.

PMID:
19293361
49.

Cyclooxygenase-2 mediates dialysate-induced alterations of the peritoneal membrane.

Aroeira LS, Lara-Pezzi E, Loureiro J, Aguilera A, Ramírez-Huesca M, González-Mateo G, Pérez-Lozano ML, Albar-Vizcaíno P, Bajo MA, del Peso G, Sánchez-Tomero JA, Jiménez-Heffernan JA, Selgas R, López-Cabrera M.

J Am Soc Nephrol. 2009 Mar;20(3):582-92. doi: 10.1681/ASN.2008020211. Epub 2009 Jan 21.

50.

Epithelial-to-mesenchymal transition of peritoneal mesothelial cells is regulated by an ERK/NF-kappaB/Snail1 pathway.

Strippoli R, Benedicto I, Pérez Lozano ML, Cerezo A, López-Cabrera M, del Pozo MA.

Dis Model Mech. 2008 Nov-Dec;1(4-5):264-74. doi: 10.1242/dmm.001321. Epub 2008 Oct 28.

Supplemental Content

Loading ...
Support Center